Reine Allan
CIK: 0001714023•Chief Financial Officer
Officer
Primary company: Prime Medicine, Inc. (PRME)
Reine Allan is a corporate insider (Chief Financial Officer) at Prime Medicine, Inc. (PRME) filing SEC Form 4 transactions. 20 transactions across 3 companies, totaling $460,500 in purchases and $0 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Award | 850,000 | - | - | 850,000 | 8/1/2025 Filed: 8/5/2025 | Filing → | |
| Disposition | 850,000 | - | - | 0 | 8/1/2025 Filed: 8/5/2025 | Filing → | |
| Purchase | 125,000 | $1.18 | $147K | 125,000 | 5/21/2025 Filed: 5/22/2025 | Filing → | |
| Award | 2,000,000 | - | - | 2,000,000 | 5/19/2025 Filed: 5/19/2025 | Filing → | |
| Award | 75,000 | - | - | 850,000 | 5/8/2025 Filed: 5/12/2025 | Filing → | |
| Award | 275,000 | $2.42 | $666K | 275,000 | 2/27/2025 Filed: 3/3/2025 | Filing → | |
| Award | 75,000 | - | - | 775,000 | 12/5/2024 Filed: 12/9/2024 | Filing → | |
| Award | 100,000 | - | - | 100,000 | 5/17/2024 Filed: 5/21/2024 | Filing → | |
| Award | 600,000 | - | - | 600,000 | 1/17/2024 Filed: 1/19/2024 | Filing → | |
| Award | 90,000 | $0.00 | $0 | 90,000 | 1/26/2023 Filed: 1/30/2023 | Filing → | |
| Award | 135,000 | $0.00 | $0 | 135,000 | 1/26/2022 Filed: 1/28/2022 | Filing → | |
| Exercise | 26,892 | $0.00 | $0 | 257,512 | 8/9/2021 Filed: 8/11/2021 | Filing → | |
| Exercise | 26,892 | $3.72 | $100K | 53,784 | 8/9/2021 Filed: 8/11/2021 | Filing → | |
| Award | 120,000 | $0.00 | $0 | 120,000 | 1/28/2021 Filed: 2/1/2021 | Filing → | |
PIERIS PHARMACEUTICALS, INC. PIRS | Award | 162,500 | $0.00 | $0 | 162,500 | 2/26/2019 Filed: 2/28/2019 | Filing → |
PIERIS PHARMACEUTICALS, INC. PIRS | Award | 50,000 | $0.00 | $0 | 50,000 | 2/20/2018 Filed: 2/26/2018 | Filing → |
PIERIS PHARMACEUTICALS, INC. PIRS | Award | 53,833 | $0.00 | $0 | 53,833 | 2/20/2018 Filed: 2/26/2018 | Filing → |
PIERIS PHARMACEUTICALS, INC. PIRS | Purchase | 20,000 | $4.89 | $98K | 65,000 | 8/17/2017 Filed: 8/17/2017 | Filing → |
PIERIS PHARMACEUTICALS, INC. PIRS | Purchase | 45,000 | $4.79 | $216K | 45,000 | 8/16/2017 Filed: 8/17/2017 | Filing → |
PIERIS PHARMACEUTICALS, INC. PIRS | Award | 450,000 | $0.00 | $0 | 450,000 | 8/9/2017 Filed: 8/11/2017 | Filing → |
Type
Award
Shares
850,000
Price
-
Value
-
Type
Disposition
Shares
850,000
Price
-
Value
-
Type
Purchase
Shares
125,000
Price
$1.18
Value
$147K
Type
Award
Shares
2,000,000
Price
-
Value
-
Type
Award
Shares
75,000
Price
-
Value
-
Type
Award
Shares
275,000
Price
$2.42
Value
$666K
Type
Award
Shares
75,000
Price
-
Value
-
Type
Award
Shares
100,000
Price
-
Value
-
Type
Award
Shares
600,000
Price
-
Value
-
Type
Award
Shares
90,000
Price
$0.00
Value
$0
Type
Award
Shares
135,000
Price
$0.00
Value
$0
Type
Exercise
Shares
26,892
Price
$0.00
Value
$0
Type
Exercise
Shares
26,892
Price
$3.72
Value
$100K
Type
Award
Shares
120,000
Price
$0.00
Value
$0
PIERIS PHARMACEUTICALS, INC.
PIRS
Type
Award
Shares
162,500
Price
$0.00
Value
$0
PIERIS PHARMACEUTICALS, INC.
PIRS
Type
Award
Shares
50,000
Price
$0.00
Value
$0
PIERIS PHARMACEUTICALS, INC.
PIRS
Type
Award
Shares
53,833
Price
$0.00
Value
$0
PIERIS PHARMACEUTICALS, INC.
PIRS
Type
Purchase
Shares
20,000
Price
$4.89
Value
$98K
PIERIS PHARMACEUTICALS, INC.
PIRS
Type
Purchase
Shares
45,000
Price
$4.79
Value
$216K
PIERIS PHARMACEUTICALS, INC.
PIRS
Type
Award
Shares
450,000
Price
$0.00
Value
$0
AI Agent
Try asking...